Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.

about

Effectiveness and safety of Glycyrrhizae Decoction for Purging Stomach-Fire in Behcet disease patients: Study protocol for a randomized controlled and double-blinding trail.

P2860

Q52622848-C8A9686C-A38F-4194-AC23-0CA3A3747441

P2860

Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.

Item

http://www.wikidata.org/entity/Q47547344

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Infliximab associated with lif ...... em involvement: A case report.

@en

Infliximab associated with lif ...... em involvement: A case report.

@nl

type

Item

label

Infliximab associated with lif ...... em involvement: A case report.

@en

Infliximab associated with lif ...... em involvement: A case report.

@nl

prefLabel

Infliximab associated with lif ...... em involvement: A case report.

@en

Infliximab associated with lif ...... em involvement: A case report.

@nl

P1476

Infliximab associated with lif ...... em involvement: A case report.

@en

P2093

Hai-Fen Ma

http://www.w3.org/2001/XMLSchema#string

Jian-Fei Cai

http://www.w3.org/2001/XMLSchema#string

Jian-Long Guan

http://www.w3.org/2001/XMLSchema#string

Yan Shen

http://www.w3.org/2001/XMLSchema#string

Yan-Qin Hua

http://www.w3.org/2001/XMLSchema#string

Yong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group

Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes.

Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.

Differential diagnosis and management of Behçet syndrome.

Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study.

Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature.

Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?

Autoimmune diseases and myelodysplastic syndromes.

P304

e9202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000009202

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jun Zou

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29390339

http://www.w3.org/2001/XMLSchema#string

P921

Behcet's disease

P932

5815751

http://www.w3.org/2001/XMLSchema#string

Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.

about

P2860

P2860

Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932